The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
A shareholder group is investing up to $3m to keep medicinal company going after creditors voted in favour of deed of company arrangement.
The company wants constitutional amendments to restrict share transfers that would otherwise jeopardise shareholder continuity requirements for the use of tax losses.
Stock falls as much as 22% after casino operator cans dividends until 2026 and cuts profit outlook.
The division’s underlying ebitda will be positively affected by the orchard purchases.
Casino operator seeks to protect debt covenant headroom as market conditions weaken.
The debt-burdened milk processor has a shareholder loan and says it is working on an equity raise, but it won't be enough, says a Forbar note.
Deal with lenders places potential restrictions on dividend payments.
A significant majority of farmers supplying the company have submitted cessation notices.
No purchase price was disclosed, but the mining multinational was given confidence in the long term viability of Tiwai Pt after its 20-year deal with NZ's energy generator trifecta.